Published in
Elsevier, Journal of Allergy and Clinical Immunology: In Practice, 8(10), p. 2099-2108.e6, 2022
DOI: 10.1016/j.jaip.2022.04.014
05.01 - Airway pharmacology and treatment, 2022
DOI: 10.1183/13993003.congress-2022.2164
Links
Tools
Real-world effectiveness of reslizumab in patients with severe eosinophilic asthma – “first initiators” and “switchers”
Journal article published in 2022 by
Simone Hashimoto 
,
Johannes A. Kroes,
Katrien A. Eger,
Pearl F. Mau-Asam,
Hendrik B. Hofstee,
Sarah A. Bendien,
Gert Jan Braunstahl,
Maarten J. van Bezouw,
Marielle E. A. C. Broeders,
Marjo J. van de Ven,
Leonie M. Imming,
Anneke van Veen,
Bas Langeveld,
Edwin van Velzen,
Anke H. Maitland-Van Der Zee
and other authors.
,
Johannes A. Kroes,
Katrien A. Eger,
Pearl F. Mau-Asam,
Hendrik B. Hofstee,
Sarah A. Bendien,
Gert Jan Braunstahl,
Maarten J. van Bezouw,
Marielle E. A. C. Broeders,
Marjo J. van de Ven,
Leonie M. Imming,
Anneke van Veen,
Bas Langeveld,
Edwin van Velzen,
Anke H. Maitland-Van Der Zee
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 